1
|
Gallet R, Saiydoun G, Gall E, Martin-Tuffreau AS, Boukantar M, Folliguet T, Teiger E. Percutaneous angio-guided versus surgical veno-arterial ECMO implantation in patients with cardiogenic shock or cardiac arrest. Archives of Cardiovascular Diseases Supplements 2023. [DOI: 10.1016/j.acvdsp.2022.10.310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
2
|
Moulin T, Hamon D, Djouadi K, D'Humières T, Elbaz N, Boukantar M, Zerbib C, Rouffiac S, Dhanjal TS, Ernande L, Derumeaux G, Teiger E, Damy T, Lellouche N. Impact of cardiac resynchronization therapy optimization inside a heart failure programme: a real-world experience. ESC Heart Fail 2022; 9:3101-3112. [PMID: 35748123 DOI: 10.1002/ehf2.14043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2022] [Revised: 05/16/2022] [Accepted: 06/03/2022] [Indexed: 11/07/2022] Open
Abstract
AIMS This study sought to describe and evaluate the impact of a routine in-hospital cardiac resynchronization therapy (CRT) programme, including comprehensive heart failure (HF) evaluation and systematic echo-guided CRT optimization. METHODS AND RESULTS CRT implanted patients were referred for optimization programme at 3 to 12 months from implantation. The program included clinical and biological status, standardized screening for potential cause of CRT non-response and systematic echo-guided atrioventricular and interventricular delays (AVd and VVd) optimization. Initial CRT-response and improvement at 6 months post-optimization were assessed with a clinical composite score (CCS). Major HF events were tracked during 1 year after optimization. A total of 227 patients were referred for CRT optimization and enrolled (71 ± 11 years old, 77% male, LVEF 30.6 ± 7.9%), of whom 111 (48.9%) were classified as initial non-responders. Left ventricular lead dislodgement was noted in 4 patients (1.8%), and loss or ≤90% biventricular capture in 22 (9.7%), mostly due to arrhythmias. Of the 196 patients (86%) who could undergo echo-guided CRT optimization, 71 (36.2%) required VVd modification and 50/144 (34.7%) AVd modification. At 6 months post-optimization, 34.3% of the initial non-responders were improved according to the CCS, but neither AVd nor VVd echo-guided modification was significantly associated with CCS-improvement. After one-year follow-up, initial non-responders maintained a higher rate of major HF events than initial responders, with no significant difference between AVd/VVd modified or not. CONCLUSIONS Our study supports the necessity of a close, comprehensive and multidisciplinary follow-up of CRT patients, without arguing for routine use of echo-guided CRT optimization.
Collapse
Affiliation(s)
- Thibaut Moulin
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - David Hamon
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Kamila Djouadi
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Thomas D'Humières
- Department of Physiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France.,INSERM U955, Université Paris-Est Créteil (UPEC), EUR LIVE, Créteil, France
| | - Nathalie Elbaz
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Madjid Boukantar
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Céline Zerbib
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Ségolène Rouffiac
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Tarvinder S Dhanjal
- Department of Cardiac Electrophysiology, University of Warwick, Coventry, UK
| | - Laura Ernande
- Department of Physiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Geneviève Derumeaux
- Department of Physiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France.,INSERM U955, Université Paris-Est Créteil (UPEC), EUR LIVE, Créteil, France
| | - Emmanuel Teiger
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Thibaud Damy
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| | - Nicolas Lellouche
- Department of Cardiology, FHU SENEC, AP-HP, University Hospital Henri Mondor, Créteil, France
| |
Collapse
|
3
|
Saiydoun G, Gall E, Boukantar M, Fiore A, Mongardon N, Masi P, Bagate F, Radu C, Bergoend E, Mangiameli A, de Roux Q, Mekontso Dessap A, Langeron O, Folliguet T, Teiger E, Gallet R. Percutaneous angio-guided versus surgical veno-arterial ECLS implantation in patients with cardiogenic shock or cardiac arrest. Resuscitation 2021; 170:92-99. [PMID: 34826577 DOI: 10.1016/j.resuscitation.2021.11.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 11/16/2021] [Accepted: 11/16/2021] [Indexed: 11/15/2022]
Abstract
BACKGROUND Veno-arterial Extracorporeal Life Support (V-A ECLS) has gained increasing place into the management of patients with refractory cardiogenic shock or cardiac arrest. Both surgical and percutaneous approach can be used for cannulation, but percutaneous approach has been associated with fewer complications. Angio-guided percutaneous cannulation and decannulation may further decrease the rate of complication. We aimed to compare outcome and complication rates in patients supported with V-A ECLS through percutaneous angio-guided versus surgical approach. METHODS We included all patients with emergent peripheral femoro-femoral V-A ECLS implantation for refractory cardiogenic shock or cardiac arrest in our center from March 2018 to March 2021. Survival and major complications (major bleeding, limb ischemia and groin infection) rates were compared between the percutaneous angio-guided and the surgical groups. RESULTS One hundred twenty patients received V-A ECLS, 59 through surgical approach and 61 through angio-guided percutaneous approach. Patients' baseline characteristics and severity scores were equally balanced between the 2 groups. Thirty-day mortality was not significantly different between the 2 approaches. However, angio-guided percutaneous cannulation was associated with fewer major vascular complications (42% vs. 11%, p > 0.0001) and a higher rate of V-A ECLS decannulation. In multivariate analysis, percutaneous angio-guided implantation of V-A ECLS was independently associated with a lower probability of major complications. CONCLUSION Compared to surgical approach, angio-guided percutaneous V-A ECLS implantation is associated with fewer major vascular complications. Larger studies are needed to confirm those results and address their impact on mortality.
Collapse
Affiliation(s)
- Gabriel Saiydoun
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Emmanuel Gall
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Madjid Boukantar
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Antonio Fiore
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Nicolas Mongardon
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France; U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire d'Alfort (EnVA), F-94700 Maisons-Alfort, France
| | - Paul Masi
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, F-94010 Créteil, France; Univ Paris Est Créteil, CARMAS, Créteil F-94010, France; Univ Paris Est Créteil, INSERM, IMRB, Créteil F-94010, France
| | - François Bagate
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, F-94010 Créteil, France; Univ Paris Est Créteil, CARMAS, Créteil F-94010, France; Univ Paris Est Créteil, INSERM, IMRB, Créteil F-94010, France
| | - Costin Radu
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Eric Bergoend
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Andrea Mangiameli
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Quentin de Roux
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France; U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire d'Alfort (EnVA), F-94700 Maisons-Alfort, France
| | - Armand Mekontso Dessap
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, F-94010 Créteil, France; Univ Paris Est Créteil, CARMAS, Créteil F-94010, France; Univ Paris Est Créteil, INSERM, IMRB, Créteil F-94010, France
| | - Olivier Langeron
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Thierry Folliguet
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France
| | - Emmanuel Teiger
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France; U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire d'Alfort (EnVA), F-94700 Maisons-Alfort, France
| | - Romain Gallet
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, F-94010 Créteil, France; U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire d'Alfort (EnVA), F-94700 Maisons-Alfort, France.
| |
Collapse
|
4
|
Bonnet G, Panagides V, Becker M, Rivière N, Yvorel C, Deney A, Lattuca B, Duband B, Moussa K, Juenin L, Pamart T, Semaan C, Uhry S, Noirclerc N, Vincent F, Vignac M, Palermo V, Martin AS, Zeitouni M, Van Belle E, Tirouvanziam A, Manchuelle A, Chamandi C, Kerneis M, Boukantar M, Belle L, De Poli F, Angoulvant D, Meneveau N, Robin M, Pansieri M, Bonello L, Motreff P, Bouisset F, Isaaz K, Cetran L, Khalife K, Lesizza P, Adjedj J, Benamer H, Cayla G. ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France. Arch Cardiovasc Dis 2021; 114:340-351. [PMID: 33926830 PMCID: PMC9056233 DOI: 10.1016/j.acvd.2021.01.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/22/2020] [Revised: 01/11/2021] [Accepted: 01/18/2021] [Indexed: 12/27/2022]
Abstract
BACKGROUND Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown. AIM To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019. METHODS In this nationwide French survey, data from consecutive STEMI patients from 65 centres referred for urgent revascularization between 1 March and 31 May 2020, and between 1 March and 31 May 2019, were analysed. The primary outcome was a composite of in-hospital death or non-fatal mechanical complications of acute myocardial infarction. RESULTS A total of 6306 patients were included. During the pandemic peak, a 13.9±6.6% (P=0.003) decrease in STEMI admissions per week was observed. Delays between symptom onset and percutaneous coronary intervention were longer in 2020 versus 2019 (270 [interquartile range 150-705] vs 245 [140-646]min; P=0.013), driven by the increase in time from symptom onset to first medical contact (121 [60-360] vs 150 [62-420]min; P=0.002). During 2020, a greater number of mechanical complications was observed (0.9% vs 1.7%; P=0.029) leading to a significant difference in the primary outcome (112 patients [5.6%] in 2019 vs 129 [7.6%] in 2020; P=0.018). No significant difference was observed in rates of orotracheal intubation, in-hospital cardiac arrest, ventricular arrhythmias and cardiogenic shock. CONCLUSIONS During the first peak of the COVID-19 pandemic in France, there was a decrease in STEMI admissions, associated with longer ischaemic time, exclusively driven by an increase in patient-related delays and an increase in mechanical complications. These findings suggest the need to encourage the population to seek medical help in case of symptoms.
Collapse
Affiliation(s)
- Guillaume Bonnet
- Université de Paris, Paris Cardiovascular Research Center (PARCC), INSERM, UMR-S970, 75015 Paris, France
| | - Vassili Panagides
- Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, 13015 Marseille, France
| | - Mathieu Becker
- CHR Metz -Thionville, Metz Hôpital de Mercy, 57530 Metz, France
| | - Nicolas Rivière
- University of Bordeaux, Cardio-thoracic intensive care unit, CHU de Bordeaux, 33600 Pessac, France
| | - Cédric Yvorel
- Cardiology Department, CHU de Saint Etienne, 42270 Saint Priest-en-Jarez, France
| | - Antoine Deney
- Cardiology Department, Rangueil University Hospital, 31400 Toulouse, France
| | - Benoit Lattuca
- Cardiology Department, Nimes University Hospital, Montpellier University, 30029 Nîmes, France
| | - Benjamin Duband
- Cardiology Department, University Hospital Gabriel Montpied, 63000 Clermont-Ferrand, France
| | - Karim Moussa
- Cardiology Department, Avignon Hôpital Center, 84140 Avignon, France
| | - Léa Juenin
- Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34000 Montpellier, France
| | - Thibault Pamart
- University of Burgundy Franche-Comté, EA3920, University Hospital Besancon, 25000 Besançon, France
| | - Carl Semaan
- Cardiology Department, University Hospital of Tours, 37000 Tours, France
| | - Sabrina Uhry
- Cardiology Department, CH de Haguenau, 67500 Haguenau, France
| | | | | | - Maxime Vignac
- Université de Paris, Paris Cardiovascular Research Center (PARCC), INSERM, UMR-S970, 75015 Paris, France
| | - Vincenzo Palermo
- Cardiology Department, Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France
| | - Anne Sophie Martin
- CHU Henri Mondor, Service de cardiologie interventionnelle, AP-HP, 94010 Créteil, France
| | - Michel Zeitouni
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France
| | | | | | | | - Chekrallah Chamandi
- Cardiology Department, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris, Université de Paris, INSERM U970, 75015 Paris, France
| | - Mathieu Kerneis
- Sorbonne Université, ACTION Study Group, INSERM UMRS1166, Hôpital Pitié-Salpêtrière (AP-HP), 75013 Paris, France
| | - Madjid Boukantar
- CHU Henri Mondor, Service de cardiologie interventionnelle, AP-HP, 94010 Créteil, France
| | - Loïc Belle
- Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France
| | - Fabien De Poli
- Cardiology Department, CH de Haguenau, 67500 Haguenau, France
| | - Denis Angoulvant
- Cardiology Department, University Hospital of Tours, 37000 Tours, France
| | - Nicolas Meneveau
- University of Burgundy Franche-Comté, EA3920, University Hospital Besancon, 25000 Besançon, France
| | - Marie Robin
- Cardiology Department, University Hospital of Montpellier, University of Montpellier, 34000 Montpellier, France
| | - Michel Pansieri
- Cardiology Department, Avignon Hôpital Center, 84140 Avignon, France
| | - Laurent Bonello
- Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, 13015 Marseille, France
| | - Pascal Motreff
- Cardiology Department, University Hospital Gabriel Montpied, 63000 Clermont-Ferrand, France
| | - Frédéric Bouisset
- Cardiology Department, Rangueil University Hospital, 31400 Toulouse, France; Department of Epidemiology, INSERM UMR 1027, 31000 Toulouse, France
| | - Karl Isaaz
- Cardiology Department, CHU de Saint Etienne, 42270 Saint Priest-en-Jarez, France
| | - Laura Cetran
- University of Bordeaux, Cardio-thoracic intensive care unit, CHU de Bordeaux, 33600 Pessac, France
| | - Khalifé Khalife
- CHR Metz -Thionville, Metz Hôpital de Mercy, 57530 Metz, France
| | | | - Julien Adjedj
- Arnaud Tzanck Institute, 06700 Saint Laurent du Var, France
| | - Hakim Benamer
- Institut Jacques Cartier, Ramsay Générale de Santé, ICPS, 91300 Massy, France
| | - Guillaume Cayla
- Cardiology Department, Nimes University Hospital, Montpellier University, 30029 Nîmes, France.
| | | |
Collapse
|
5
|
Martin-Tuffreau AS, Bagate F, Boukantar M, Saiydoun G, Mangiameli A, Rostain L, Mouillet G, Fiore A, Langeron O, Mekontso-Dessap A, Mongardon N, Folliguet T, Teiger E, Gallet R. Complete percutaneous angio-guided approach using preclosing for venoarterial extracorporeal membrane oxygenation implantation and explantation in patients with refractory cardiogenic shock or cardiac arrest. Crit Care 2021; 25:93. [PMID: 33678169 PMCID: PMC7938494 DOI: 10.1186/s13054-021-03522-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Accepted: 03/01/2021] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND The approach for veno-arterial extracorporeal membrane oxygenation implantation (VA-ECMO) in patients with cardiogenic shock can be either surgical or percutaneous. Complete angio-guided percutaneous implantation and explantation could decrease vascular complications. We sought to describe the initial results of complete percutaneous angio-guided ECMO implantation and explantation using preclosing. METHODS All consecutive patients who underwent peripheral femoro-femoral VA-ECMO percutaneous implantation for refractory cardiogenic shock or cardiac arrest were enrolled in a prospective registry (03/2018-12/2020). Percutaneous preclosing using two closing devices (Perclose ProGlide, Abbott) inserted before cannulation was used in both femoral artery and vein. Explantation was performed using a crossover technique under angiographic guidance. The occurrence of vascular complication was recorded. RESULTS Among the 56 patients who underwent percutaneous VA-ECMO implantation for cardiogenic shock or refractory cardiac arrest, 41 underwent preclosing. Femoral vessel cannulation was successful in all patients and total cannulation time was 20 (10-40) min. Weaning from ECMO was possible in 22/41 patients (54%) and 12 (29%) patients were alive at day 30. Significant vascular complications occurred in 2/41 patients. Percutaneous decannulation was performed in 20 patients with 19/20 technical success rate. All femoral arteries and veins were properly closed using the pre-closing devices without bleeding on the angiographic control except for one patient in whom surgical closure of the artery was required. No patient required transfusion for access related significant bleeding and no other vascular complication occurred. Furthermore, no groin infection was observed after full percutaneous implantation and removal of ECMO. CONCLUSION Emergent complete percutaneous angio-guided VA-ECMO implantation and explantation using pre-closing technique can be an attractive strategy in patients referred for refractory cardiogenic shock.
Collapse
Affiliation(s)
- Anne-Sophie Martin-Tuffreau
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
| | - François Bagate
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, 94010, Créteil, France
- Univ Paris Est Créteil, CARMAS, 94010, Créteil, France
- Univ Paris Est Créteil, INSERM, IMRB, 94010, Créteil, France
| | - Madjid Boukantar
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
| | - Gabriel Saiydoun
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, 94010, Créteil, France
| | - Andrea Mangiameli
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
| | - Laura Rostain
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
| | - Gauthier Mouillet
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
| | - Antonio Fiore
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, 94010, Créteil, France
| | - Olivier Langeron
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010, Créteil, France
| | - Armand Mekontso-Dessap
- AP-HP, Hôpitaux Universitaires Henri-Mondor, Service de Médecine Intensive Réanimation, 94010, Créteil, France
- Univ Paris Est Créteil, CARMAS, 94010, Créteil, France
- Univ Paris Est Créteil, INSERM, IMRB, 94010, Créteil, France
| | - Nicolas Mongardon
- Service d'anesthésie-réanimation chirurgicale, DMU CARE, DHU A-TVB, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, 94010, Créteil, France
- U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire D'Alfort (EnVA), 94700, Maisons-Alfort, France
| | - Thierry Folliguet
- Department of Cardiac Surgery, APHP, Hôpitaux Universitaires Henri Mondor, 94010, Créteil, France
| | - Emmanuel Teiger
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France
- U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire D'Alfort (EnVA), 94700, Maisons-Alfort, France
| | - Romain Gallet
- Service de Cardiologie, APHP, Hôpitaux Universitaires Henri Mondor, 41 avenue du Maréchal de Lattre de Tassigny, 94000, Créteil, France.
- U955-IMRB, Equipe 03, Inserm, Univ Paris Est Creteil (UPEC), Ecole Nationale Vétérinaire D'Alfort (EnVA), 94700, Maisons-Alfort, France.
| |
Collapse
|
6
|
Martin-Tuffreau A, Bagate F, Boukantar M, Mouillet G, Saiydoun G, Mangiameli A, Rostain L, Folliguet T, Teiger E, Gallet R. Total angio-guided percutaneous implantation and removal of veno-arterial extracorporeal membrane oxygenation using pre-closing technique, a retrospective monocentric experience. Archives of Cardiovascular Diseases Supplements 2021. [DOI: 10.1016/j.acvdsp.2020.10.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
7
|
Koutsoukis A, Fard D, Gallet R, Boukantar M, Teiger E, Nguyen A, Huguet R, Lim P. MitraClip Implantation for Functional Mitral Regurgitation With Coaptation Gap Facilitated by Levosimendan Treatment. JACC Case Rep 2020; 2:862-865. [PMID: 34317368 PMCID: PMC8302007 DOI: 10.1016/j.jaccas.2020.04.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Revised: 04/13/2020] [Accepted: 04/14/2020] [Indexed: 11/05/2022]
Abstract
A patient with severe, symptomatic functional mitral regurgitation was initially considered not suitable for MitraClip (Abbott Vascular, Abbott Park, Illinois) implantation because of non-coapting mitral leaflets. Repeated levosimendan infusions in combination with intensive diuresis induced sufficient valve coaptation, thus allowing MitraClip implantation to be performed. (Level of Difficulty: Intermediate.)
Collapse
|
8
|
Takahashi M, Mouillet G, Khaled A, Boukantar M, Gallet R, Rubimbura V, Lim P, Dubois-Rande JL, Teiger E. Perioperative Outcomes of Adjunctive Hypnotherapy Compared with Conscious Sedation Alone for Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation. Int Heart J 2020; 61:60-66. [DOI: 10.1536/ihj.19-296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Affiliation(s)
- Masao Takahashi
- Department of Cardiology, Henri Mondor University Hospital
- Department of Cardiovascular Medicine, Jichi Medical University School of Medicine
| | | | - Asmaa Khaled
- Department of Anesthesiology, Henri Mondor University Hospital
| | | | - Romain Gallet
- Department of Cardiology, Henri Mondor University Hospital
| | | | - Pascal Lim
- Department of Cardiology, Henri Mondor University Hospital
| | | | | |
Collapse
|
9
|
Rostain L, Gallet R, Mouillet G, Boukantar M, Ternacle J, Teiger E. Left ventricule perforation during percutaneous aortic-valve implantation: Epidemiologic data and risk factors. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
10
|
Boukantar M, Loyeau A, Gallet R, Bataille S, Benamer H, Caussin C, Garot P, Livarek B, Varenne O, Spaulding C, Karrillon G, Teiger E. Angiography and Percutaneous Coronary Intervention for Chronic Total Coronary Occlusion in Daily Practice (from a Large French Registry [CARDIO-ARSIF]). Am J Cardiol 2019; 124:688-695. [PMID: 31307663 DOI: 10.1016/j.amjcard.2019.05.062] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Revised: 05/19/2019] [Accepted: 05/21/2019] [Indexed: 02/03/2023]
Abstract
The aim of this study was to provide contemporary data on chronic total occlusion (CTO) prevalence and management in a large unselected population representing the daily activity of cathlabs, in the greater Paris area, and to compare percutaneous coronary intervention (PCI) features in patients with and without CTO. Procedures were collected from the CARDIO-ARSIF (Agence Régionale de Santé Ile de France) registry from 2012 to 2015. Patients with acute coronary syndrome or previous coronary artery bypass grafting were excluded. CTO features were assessed and PCIs with and without CTO were compared. Among 128,739 included patients, 10,468 (8.1%) had at least 1 CTO. Cardiovascular risk-factor burden was higher in the CTO group, which had more patients with multivessel disease (74% vs 24%) and with referral for interventional management (59% vs 33%). Of all PCIs during the study period, 5.7% involved a CTO; this proportion increased significantly over the study period. PCI success rate was 75.9% in the CTO group. CTO-PCI volume per center did not correlate with CTO-PCI success rate. In conclusion, CTO is common in patients who underwent scheduled coronary angiography. Invasive management is done more often in patients with than without CTO. The success rate of PCI in CTO is not associated with case volume per center.
Collapse
Affiliation(s)
- Madjid Boukantar
- Interventional Cardiology, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, France.
| | - Aurélie Loyeau
- Agence Régionale de Santé d'Ile-de-France (ARSIF), Paris, France
| | - Romain Gallet
- Interventional Cardiology, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, France
| | - Sophie Bataille
- Agence Régionale de Santé d'Ile-de-France (ARSIF), Paris, France
| | - Hakim Benamer
- Hôpital Privé Jacques Cartier, Institut Cardiovasculaire Paris Sud (ICPS), Massy, France
| | | | - Philippe Garot
- Hôpital Privé Jacques Cartier, Institut Cardiovasculaire Paris Sud (ICPS), Massy, France
| | - Bernard Livarek
- Cardiology Department, Versailles Hospital (André Mignot), Le Chesnay, France
| | - Olivier Varenne
- Cardiology Department, University Hospital Cochin, Assistance Publique-Hôpitaux de Paris, France
| | - Christian Spaulding
- Cardiology Department, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, France
| | | | - Emmanuel Teiger
- Interventional Cardiology, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, France
| |
Collapse
|
11
|
El Ayech F, Ternacle J, Boudiche S, Gallet R, Boukantar M, Hamon D, Nguyen A, Riant E, Mouillet G, Teiger E, Lellouche N. Percutaneous Left Atrial Appendage Closure in Patients With Inferior Vena Cava Filters: A Case Series. J Invasive Cardiol 2019; 31:128-132. [PMID: 31034435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
OBJECTIVES Percutaneous procedures through femoral access in patients with inferior vena cava (IVC) filter may be at risk of complications. We evaluated the feasibility and safety of left atrial appendage (LAA) closure through femoral access in patients previously implanted with IVC filter. METHODS From November 2011 to March 2018, a total of 5 patients with history of IVC filter implantation were referred to our center for percutaneous LAA closure, representing 3.6% of the 137 procedures performed during the study period. The IVC filter devices were placed from 2 to 26 months before the index procedure. RESULTS LAA closure was successfully implanted in all cases using an Amulet device in 3 patients and a Watchman device in 2 patients. A femoral approach was performed in all patients using 12 or 14 Fr sheaths. Before crossing IVC filters, venographies did not detect any thrombus. All steps of IVC filter crossing were performed under fluoroscopic guidance. No immediate or late complications related to the procedure occurred after 10.1 ± 3.9 months of follow-up. CONCLUSION LAA closure in patients with previously implanted IVC filter is safe as long as careful x-ray monitoring is observed.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Nicolas Lellouche
- Service de Cardiologie Hôpital Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94000 Creteil, France.
| |
Collapse
|
12
|
Rubimbura V, Rostain L, Duval AM, Akakpo S, Boukantar M, Boiron P, Mouillet G, Gallet R, Belarbi A, Le Corvoisier P, Dubois-Randé JL, Teiger E. Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study. Catheter Cardiovasc Interv 2019; 94:105-111. [PMID: 30702204 DOI: 10.1002/ccd.28084] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/03/2018] [Revised: 12/27/2018] [Accepted: 12/31/2018] [Indexed: 02/05/2023]
Abstract
AIMS Same-day discharge (SDD) after percutaneous coronary intervention (PCI) was safe and cost-effective in randomized and observational studies but faces limited acceptance due to concerns about early adverse events. Our aim was to evaluate early outcomes after SDD PCI in a high-volume urban PCI center over 10 years. METHODS AND RESULTS From 2007 to 2016, 1,635 unselected patients had PCI at our ambulatory cardiac care unit, mainly for stable ischemic heart disease (SIHD). Among them, 1,073 (65.6%), most of whom underwent ad hoc PCI, were discharged on the same day and 562 (34.4%) were admitted, for adverse events during PCI (n = 60) or within the next 4-6 hr (n = 52) or chiefly due to physician preference (n = 450). In the SDD group, radial access was used in 98.5% of patients; 36% and 15% of patients had two- and three-vessel disease, respectively; and two-vessel PCI was performed in 11% of patients. No MACCEs (death, myocardial infarction, stroke, urgent repeat PCI/CABG, and major vascular complications) occurred within 24 hr post-discharge. Two patients were readmitted on the next day for chest pain but did not require repeat PCI. CONCLUSION SDD after successful PCI without complications within the next 4-6 hr is safe and feasible in most patients with SIHD. Among 1,035 SDD patients treated over 10 years, only two required readmission, and none experienced major cardiac adverse events such as death or stent thrombosis. SDD is safe for the patient and cost-effective for the healthcare system and should be implemented more widely.
Collapse
Affiliation(s)
- Vladimir Rubimbura
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Laura Rostain
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Anne-Marie Duval
- Department of Cardiology, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Servais Akakpo
- Department of Cardiology, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Madjid Boukantar
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Philippe Boiron
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Gauthier Mouillet
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Romain Gallet
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | - Abdelkaoui Belarbi
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France
| | | | - Jean-Luc Dubois-Randé
- Department of Cardiology, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France.,Inserm, CIC 1430 et U955 team 3, Henri Mondor University Hospital, Créteil, France
| | - Emmanuel Teiger
- Interventional Cardiology Unit, Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Créteil, France.,Inserm, CIC 1430 et U955 team 3, Henri Mondor University Hospital, Créteil, France
| |
Collapse
|
13
|
Nguyen A, Gallet R, Riant E, Deux JF, Boukantar M, Mouillet G, Dubois-Randé JL, Lellouche N, Teiger E, Lim P, Ternacle J. Peridevice Leak After Left Atrial Appendage Closure: Incidence, Risk Factors, and Clinical Impact. Can J Cardiol 2018; 35:405-412. [PMID: 30935631 DOI: 10.1016/j.cjca.2018.12.022] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2018] [Revised: 11/25/2018] [Accepted: 12/13/2018] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Limited studies reported the rate and clinical impact of peridevice leaks (PDL) after percutaneous left atrial appendage closure (LAAC). METHODS All consecutive patients with a nonvalvular atrial fibrillation admitted for LAAC between November 2011 and October 2016 were prospectively enrolled. The follow-up included clinical, transesophageal echocardiography, and/or cardiac computed tomography angiogram (CCTA). PDL was defined by the presence of contrast within the left atrial appendage on CCTA, and Major Adverse Cardiac Event (MACE) included stroke, device-related thrombosis, and cardiovascular death. RESULTS Overall, 77 patients (mean CHA2DS2-VASc score = 4.4 ± 1.5 and mean HAS-BLED = 3.4 ± 1.1) were implanted using Amplatzer Cardiac Plug (n = 24), Amulet (n = 37), or Watchman devices (n = 16). Indications were stroke recurrence despite adequate oral anticoagulation (OAC, n = 6) or contraindication to long-term OAC (n = 71). From 3-month to 12-month CCTA follow-up, the PDL rate decreased from 68.5% to 56.7% (P = 0.02), without any difference between the various devices. Patients with PDL were more often in permanent atrial fibrillation, and had a larger landing zone diameter, a lower ratio of device compression, and a more frequent off-axis position of the device. A device compression ratio < 10% was the only parameter associated with PDL occurrence. During follow-up (median 236 days) the MACE rate was 9.1%, with no statistically significant difference between patients with vs without PDL (12% vs 4.3%, P = 0.3). CONCLUSIONS The PDL rate detected by CCTA after LAAC was high, especially in cases with a low device compression ratio (< 10%), but decreased over time. The incidence of MACE was quantitatively greater with PDL, but the difference was not statistically significant. Larger studies are needed to determine the clinical importance of PDL.
Collapse
Affiliation(s)
- Annabelle Nguyen
- Cardiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Romain Gallet
- Interventional Cardiology Unit, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Elisabeth Riant
- Cardiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Jean-François Deux
- Radiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Madjid Boukantar
- Interventional Cardiology Unit, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Gauthier Mouillet
- Interventional Cardiology Unit, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | | | - Nicolas Lellouche
- Cardiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Emmanuel Teiger
- Interventional Cardiology Unit, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Pascal Lim
- Cardiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France
| | - Julien Ternacle
- Cardiology Department, Expert Valve Center, Henri Mondor Hospital, Créteil, France.
| |
Collapse
|
14
|
Boukantar M, Teiger E. P3637Contemporary perspectives on coronary chronic total occlusion: data from a vast French registry (Cardio-ARSIF). Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3637] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- M Boukantar
- University Hospital Henri Mondor, Creteil, France
| | - E Teiger
- University Hospital Henri Mondor, Creteil, France
| | | |
Collapse
|
15
|
Nguyen A, Riant E, Gallet R, Boukantar M, Rubimbura V, Akakpo S, Duval A, Deux J, Dubois-Rande J, Teiger E, Lim P, Ternacle J. Does peri-device leak after left atrial appendage closure impact patient outcome? Archives of Cardiovascular Diseases Supplements 2018. [DOI: 10.1016/j.acvdsp.2017.11.326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Rubimbura Mazimpaka V, Rostain L, Duval A, Akakpo S, Boukantar M, Boiron P, Dubois-Rande J, Teiger E. 5705Outcome and safety of same-day discharge after percutaneous coronary intervention: a 10 year single center experience. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5705] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
17
|
Boukantar M, Gallet R, You K, Tacher V, Mouillet G, Kobeiter H, Teiger E, Hildebrandt HA, Rassaf T, Kahlert P, Boudjemline Y. How should I treat a pulmonary artery rupture occurring during a right heart catheterisation in the cathlab? EUROINTERVENTION 2017; 12:e2280-e2282. [PMID: 28391223 DOI: 10.4244/eij-d-16-00576] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Affiliation(s)
- Madjid Boukantar
- Henri Mondor Hospital, Explorations Fonctionnelles, Interventional Cardiology, Créteil, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Boukantar M, Gallet R, Mouillet G, Belarbi A, Rubimbura V, Ternacle J, Dubois-Rande JL, Teiger E. Coronary Procedures After TAVI With the Self-Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter. J Interv Cardiol 2017; 30:56-62. [PMID: 28078734 DOI: 10.1111/joic.12363] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
OBJECTIVES To evaluate the feasibility of coronary procedures after transcatheter aortic valve implantation (TAVI) with the CoreValve™ device. BACKGROUND Due to its design, CoreValve™ prosthesis may interfere with coronary procedures. Data on this issue are sparse. METHODS Between 2007 and 2015, 550 patients underwent CoreValve™ TAVI in our hospital. Among them, 16 underwent coronary angiogram after TAVI and were included in our retrospective study. For each patient, we compared the characteristics of coronary angiograms performed before and after TAVI. RESULTS Coronary angiogram was deemed successful in 9 patients. The mean number of different catheters used in attempts to cannulate the coronary arteries was 3.6 ± 1.4 and the rate of selective intubation was low. Fluoroscopy time (13.2 ± 5.8 vs. 7.2 ± 4.6 min, P = 0.003), dose area product (5,347 ± 4,919 vs. 3,433 ± 3,420 cGy/m2 , P = 0.004), and contrast volume (157.7 ± 69.6 vs. 108.3 ± 42.6 mL, P = 0.006) were more important in coronary angiograms performed after CoreValve™ implantation. Percutaneous coronary intervention was successfully performed in 6 out of 7 patients who required it. CONCLUSION Coronary procedures after CoreValve™ TAVI are feasible, but challenging. This problem is currently rare but will be more common as the indications of TAVI are expanded to younger patients with longer life expectancies. Recommendations for post-TAVI coronary procedures are needed, particularly for centers unfamiliar with the management of post-TAVI patients.
Collapse
Affiliation(s)
- Madjid Boukantar
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | - Romain Gallet
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | - Gauthier Mouillet
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | - Abdelkaoui Belarbi
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | - Vladimir Rubimbura
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | - Julien Ternacle
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| | | | - Emmanuel Teiger
- Department of Cardiovascular, Henri Mondor University Hospital, Creteil, France
| |
Collapse
|
19
|
Boukantar M, Gallet R, Mouillet G, Teiger E. Coronary procedures in patients treated by TAVI with the self-expanding aortic bioprosthesis Medtronic CoreValve ©, not an easy matter. Archives of Cardiovascular Diseases Supplements 2017. [DOI: 10.1016/s1878-6480(17)30078-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
20
|
Boukantar M, Cueff C, Brochet E, Vahanian A, Messika Zeitoun D. Transoesophageal echocardiography: an unusual trigger to Takotsubo cardiomyopathy. Eur Heart J Cardiovasc Imaging 2011; 13:445. [PMID: 22207344 DOI: 10.1093/ejechocard/jer295] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Madjid Boukantar
- AP-HP, Cardiovascular Division, Bichat Hospital, 46 rue Henri Huchard, Paris 75018, France
| | | | | | | | | |
Collapse
|
21
|
Boukantar M, Cueff C, Brochet E, Vahanian A, Messika-Zeitoun D. Transesophageal echocardiography, an unusual trigger to Takotsubo cardiomyopathy: A case report. Arch Cardiovasc Dis 2011. [DOI: 10.1016/j.acvd.2011.03.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
22
|
Affiliation(s)
- Madjid Boukantar
- Fédération de Cardiologie, Henri Mondor, 51 avenue du Maréchal de Lattre de Tassigny, Créteil 94000, France
| | | | | |
Collapse
|